Phenotypic and molecular characterization of antimicrobial resistance and virulence factors in pseudomonas aeruginosa clinical isolates from recife, state of pernambuco, brazil;Caracterização fenotípica e molecular de fatores de resistência a antimicrobianos e virulência de isolados clínicos de pseudomonas aeruginosa de recife, estado de pernambuco, Brasil

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 45, Issue 6, 2012, Pages 707-712

  De Araújo Jácome, Paula Regina Luna ^a   Alves, Lílian Rodrigues ^a   Cabral, Adriane Borges ^a   Lopes, Ana Catarina Souza ^a   Maciel, Maria Amélia Vieira ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Carbapenemase; Multidrug resistance; Pseudomonas aeruginosa; Virulence factors

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GELATINASE; GENTAMICIN; HEMOLYSIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; POLYMYXIN B; PYOCYANINE; TIMENTIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLA IMP GENE; BLA SPM 1 GENE; BLA VIM GENE; BRAZIL; CLONE; METALLO BETA LACTAMASE GENE; MOLECULAR TYPING; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PUBLIC HOSPITAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BRAZIL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; PHENOTYPE; PSEUDOMONAS AERUGINOSA; VIRULENCE FACTORS;

PSEUDOMONAS AERUGINOSA;

EID: 84872306777     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822012000600010     Document Type: Article

References (56)

1. Pitt TL, Simpson AJ. Pseudomonas and Burkholderia spp. In: Gillespie SH, Hawkey PM, editors. Principles and Practice of Clinical Bacteriology. 2nd ed. London: John Wiley & Sons; 2006. p. 427-443.
2. Winn Jr WC, Allen SD, Janda WM, Koneman E, Procop G, Schreckenberger PC, et al. Bacilos gram-negativos não fermentadores. In: Toros EF, editor. Koneman Diagnostico Microbiológico, Texto e Atlas Colorido, 6th ed. Rio de Janeiro: Guanabara Koogan; 2008. p. 302-386.
3. Zavascki AP, Barth AL, Fernandes JF, Moro ALD, Gonçalves ALS, Goldani LZ. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-β-lactamase-mediated multidrug resistance: a prospective observational study. Crit Care 2006; 10:100-110.
4. Layeux B, Taccone FS, Fagnoul D, Vincent JL, Jacobs F. Amikacin monotherapy for sepsis caused by panresistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2010; 54:4939-4941.
5. Todar K. The mechanisms of bacterial pathogenicity. Todar's Online Textbook of Bacteriology.2009 [Internet]. [Cited 2010 August 28]. Available from: http://textbookbacteriology.net/themicrobialword/pathogenesis.html.
6. Ciofu O, Lee B, Johannesson M, Hermansen NO, Meyer P, Høiby N. Scandinavian cystic fibrosis study consortium. Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology 2008; 154:103-113.
7. Cevahir N, Demir M, Kaleli I, Gurbuz M, Tikvesli S. Evalution of biofilm production, gelatinase activity, and mannose-resistent hemagglutination Acinetobacter baumannii strains. J Microbiol Immunol Infect 2008; 41:513-518.
8. Jones AK, Fulcher NB, Balzer GJ, Urbanowski ML, Pritchett CL, Schurr MJ, et al. Activation of the Pseudomonas aeruginosa AlgU regulon through mucA mutation inhibits cyclic AMP/Vfr signaling. J Bacteriol. 2010; 192:5709-5717.
9. Balasubramanian D, Schneper L, Merighi M, Smith R, Narasimhan G, Lory S, et al. The regulatory repertoire of Pseudomonas aeruginosa AmpC ß- lactamase regulator AmpR includes virulence genes. PLoS One 2012; 7:e34067.
10. Tam VH, Chang KT, Abdelraouf K, Brioso CG, Ameka M, McCaskey LA, et al. Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2010; 54:1160-1164.
11. Gales AC, Menezes LC, Silbert S, Sader HS. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. J Antimicrob Chemother 2003; 52:699-702.
12. Mendes RE, Castanheira M, Pignatari ACC, Gales AC. Metallo-β-lactamases. J Bras Patol Med Lab 2006; 42:103-113.
13. Gräf T, Fuentefria DB, Corção G. Ocorrência de isolados de Pseudomonas aeruginosa multirresistentes produtoras de metallo-β-lactamase blaSPM-1 em amostras clínicas. Rev Soc Bras Med Trop 2008; 41:306-308.
14. Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010; 36:8-14.
15. Samuelsen O, Buaro L, Toleman MA, Giske CG, Hermansen NO, Walsh TR, et al. The first metallo-beta-lactamase identified in Norway is associated with a TniC-like transposon in a Pseudomonas aeruginosa isolate of sequence type 233 imported from Ghana. Antimicrob Agents Chemother 2010; 53:331-332.
16. Spacov ICG, Silva SAM, Morais Júnior MA, Morais MMC. Polymorphism of the rDNA and tDNA loci in clinical isolates of Pseudomonas aeruginosa: A perspective for molecular epidemiology surveillance. Genet Mol Biol 2006; 29:722-729.
17. Hafiane A, Ravaoarinoro M. Différentes méthodes de typage des souches de Pseudomonas aeruginosa isolées des patients atteints de mucoviscidose. Med Mal Infect 2008; 38:238-247.
18. Pinna A, Usai D, Sechi LA, Molicotti P, Zanetti S, Carta A. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers. Cornea 2008; 27:320-326.
19. Wolska K, Szweda P. A comparative evaluation of PCR Ribotiping and ERIC PCR for determining the diversity of clinical Pseudomonas aerugnosa isolates. Pol J Microbiol 2008; 57:157-163.
20. Garrity G. Bergey's Manual® of Systematic Bacteriology. Vol 2: The Proteobacteria, Part A Introductory Essays. 2nd ed. Softcover; 2005.
21. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 20th informational supplement. M100-S20. Wayne, Pennsylvania: CLSI; 2010.
22. Arakawa Y, Shibata S, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, et al. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000; 38:40-43.
23. Dong F, Xu XW, Song WQ, Lü P, Yu SJ, Yang YH, et al. Characterization of multidrug-resistant and metallo-betalactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China. Chin Med J 2008; 121:1611-1616.
24. Duan H, Chai T, Liu J, Zhang X, Qi C, Gao J, et al. Source identification of airborne Escherichia coli of swine house surroundings using ERIC-PCR and REP-PCR. Environ Res 2009; 109:511-517.
25. Deptuła A, Gospodarek E. Reduced expression of virulence factors in multidrug-resistant Pseudomonas aeruginosa strains. Arch Microbiol 2010; 192:79-84.
26. Lee B, Haagensen JAJ, Ciofu O, Andersen JB, Høiby N, Molin N. Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 2005; 43: 5247-5255.
27. Kong F, Young L, Chen Y, Ran H, Meyers M, Joseph P. Pseudomonas aeruginosa pyocyanin inactivates lung epithelial vacuolar ATPase-dependent cystic fibrosis transmembrane conductance regulator expression and localization. Cell Microbiol 2006; 8:1121-1133.
28. Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL, Winstanley C. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol 2007; 7:1-10.
29. Iwalokun BA, Akinsinde KA, Lanlenhin O, Onubogu CC. Bacteriocinogenicity and production of pyocins from Pseudomonas species isolated in Lagos, Nigeria. Afr J Biotechnol 2006; 5:1072-1077.
30. Magalhães V, Lins AK, Magalhães M. Metallo-β-lactamase producing Pseudomonas aeruginosa strains isolated in hospitals in Recife, PE, Brazil. Braz J Microbiol 2005; 36:123-125.
31. Stehling EG, Silveira WD, Leite DS. Study of Biological Characteristics of Pseudomonas aeruginosa Strains Isolated from Patients with Cystic Fibrosis and from Patients with Extra-Pulmonary Infections. Braz J Infect Dis 2008; 12:86-88.
32. Pires EJVC, Silva Júnior VV, Lopes ACS, Veras DL, Leite LE, Maciel MAV. Epidemiologic analysis of clinical isolates of Pseudomonas aeruginosa from an university hospital. Rev Bras Ter Intensiva 2009; 21:384-390.
33. Figueiredo EAP, Ramos H, Maciel MAV, Vilar MCM, Loureiro NG, Pereira RG. Pseudomonas aeruginosa: Freqüência de resistência a múltiplos fármacos e resistência cruzada entre antimicrobianos no Recife/PE. Rev Bras Ter Intensiva 2007; 19:421-427.
34. McGowan Jr JE. Resistance in nonfermenting gram-negative bac teria: multidrug resistance to the maximum. Am J Med 2006; 119:29-36.
35. Raja NS, Singh NN. Antimicrobial susceptibility pattern of clinical iso lates of Pseudomonas aeruginosa in a tertiary care hospital. J Microbiol Immunol Infect 2007; 40:45-49.
36. Neves MT, Lorenzo MEP, Almeida RAMB, Fortaleza CMCB Antimicrobial use and incidence of multidrug-resistant Pseudomonas aeruginosa in a teaching hospital: an ecological approach. Rev Soc Bras Med Trop 2010; 43:629-632.
37. Amutha R, Padmakrishnan, Murugan T, Renuga devi MP. Studies on multidrug resistant Pseudomonas aeruginosa from pediatric population with special reference to extended spectrum beta lactamase. Indian J Sci Technol 2009; 2:11-13.
38. Figueiredo DQ, Castro LFS, Santos KRN, Teixeira LM, Mondino SSB. Detecção de metalo-beta-lactamases em amostras hospitalares de Pseudomonas aeruginosa e Acinetobacter baumannii. J Bras Patol Med Lab 2009; 45:177-184.
39. Salabi AE, Toleman MA, Weeks J, Bruderer T, Frei R, Walsh TR. First report of the metallo-β-lactamase SPM-1 in Europe. Antimicrob Agents Chemother 2010; 54:582.
40. Santos-Filho L, Santos I, Xavier DE, Menezes LC. Tipagem molecular de amostras de Pseudomonas aeruginosa produtoras de metalo-β-lactamases isoladas em João Pessoa/PB, Brasil. Rev Bras Anal Clin 2003; 35:127-131.
41. Poirel L, Magalhães M, Lopes M, Nordmann P. Molecular analysis of metallo-β-lactamase gene blaSPM-1-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil. Antimicrob Agents Chemother 2004; 48:1406-1409.
42. Cipriano R, Vieira VV, Fonseca EL, Rangel K, Freitas FS, Vicente ACP. Coexistence of epidemic colistin-only-sensitive clones of Pseudomonas aeruginosa, including the blaSPM clone, spread in hospitals in a Brazilian Amazon City. Microb Drug Resist 2007; 13:142-146.
43. Mendes RE, Toleman MA, Ribeiro J, Sader HS, Ronald N, Jones RN, et al. Integron carrying a novel metallo-β-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2004; 48:4693-4702.
44. Zavascki AP, Gaspareto PB, Martins AF, Gonçalves AL, Barth AL. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil. J Antimicrob Chemother 2005; 56:1148-1151.
45. Martins AF, Zavascki AP, Gaspareto PB, Barth AL. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-β-lactamases in hospitals from southern Brazil. Infection 2007; 35:457-460.
46. Wirth FW, Picoli SU, Cantarelli VV, Gonçalves ALS, Brust FR, Santos LMO, et al. Metallo-β-lactamase-producing Pseudomonas aeruginosa in two hospitals from Southern Brazil. Braz J Infect Dis 2009; 13:170-172.
47. Cezário RC, De-Morais LD, Jferreira JC, Costa-Pinto RM, Darini ALC, Gontijo-Filho PP. Nosocomial outbreak by imipenem-resistant metallo-β-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital. Enferm Infecc Microbiol Clin 2009; 27:269-274.
48. Sader HS, Reis AO, Silber S, Gales AC. IMPs, VIMs, SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clin Microbiol Infect 2005; 11:73-76.
49. Franco MRG, Caiaffa-Filho HH, Burattini MN, Rossi F. Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a brazilian university hospital. Clin Sci 2010; 65:825-829.
50. Carvalho APDA, Albano RM, Oliveira DN, Cidade DAP, Teixeira LM, Marques EA. Characterization of an Epidemic Carbapenem-Resistant Pseudomonas aeruginosa Producing SPM-1 Metallo-β-Lactamase in a Hospital Located in Rio de Janeiro, Brazil. Microb Drug Resist 2006; 12:103-108.
51. Scheffer MA, Gales AC, Barth AL, Filho JRC. Dalla-Costa LM. Carbapenem-resistant Pseudomonas aeruginosa - clonal spread in southern Brazil and in the state of Goiás. Braz J Infect Dis 2010; 14:508-509.
52. th ASM General Metting; 2001.
53. Toleman MA, Simm AM, Murphy TA, Gales AC, Biedenbach DJ, Jones RN, et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY Antimicrobial Surveillance Program. J Antimicrob Chemother 2002; 50:673-679.
54. Mansour W, Poirel L, Bettaieb D, Bouallegue O, Boujaafar N, Nordmann P. Metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Diagn Microbiol Infect Dis 2009; 64:458-461.
55. Lee MF, Peng CF, Hsu HJ, Chen YH. Molecular characterisation of the metallo-β-lactamase genes in imipenem-resistant gram-negative bacteria from a university hospital in southern Taiwan. Int J Antimicrob Agents 2008; 32:475-480.
56. Freitas AL, Barth AL. Typing of Pseudomonas aeruginosa from hospitalized patients: a comparison of susceptibility and biochemical profiles with genotype. Braz J Med Biol Res 2004; 37:77-82.